Evaluation of sorafenib for advanced hepatocellular carcinoma with low α-fetoprotein in arrival time parametric imaging using contrast-enhanced ultrasonography
Crossref DOI link: https://doi.org/10.1007/s10396-016-0757-2
Published Online: 2016-11-11
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shiozawa, Kazue
Watanabe, Manabu
Ikehara, Takashi
Shimizu, Ryo
Shinohara, Mie
Igarashi, Yoshinori
Sumino, Yasukiyo
License valid from 2016-11-11